La Jolla Pharmaceutical Company is a biopharmaceutical company that specializes in the development of life-saving medicines. Its main focus is on creating therapeutics to treat severe illnesses. The company is working on two main treatments: LJPC-501, an angiotensin II potential treatment for catecholamine-resistant hypotension and hepatorenal syndrome, and GCS-100, a galectin-3 inhibitor with the potential to treat chronic kidney disease. La Jolla Pharmaceutical Company is dedicated to improving quality of life for patients worldwide.
La Jolla Pharmaceutical Company's ticker is LJPC
The company's shares trade on the NASDAQ stock exchange
They are based in San Diego, California
There are 51-200 employees working at La Jolla Pharmaceutical Company
It is http://lajollapharmaceutical.com/
La Jolla Pharmaceutical Company is in the Healthcare sector
La Jolla Pharmaceutical Company is in the Biotechnology industry
The following five companies are La Jolla Pharmaceutical Company's industry peers: